31 August 2015 - Deborah Wilkes
Archived
Germany's Stada Arzneimittel has acquired Austria's Sciotec Diagnostics Technologies, including its Daosin brand, for €17.2 million (US$19.1 million) in cash.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.